Search - tctmd.com

Displaying 1 - 20 of 80

Sort: Relevancy | Date

Presentation TCT 2024

AS in Women

Presenter: Renuka Jain

October 29, 2024

Presentation TCT 2024

Case Background and Valve Selection Discussion

Presenter: Bruce Rutkin

October 29, 2024

Presentation TCT 2024

Case Outcome

Presenter: Bruce Rutkin

October 29, 2024

Presentation TCT 2024

The Evolution of Transcatheter Mitral Valve Repair: Technical and Procedural Insights from an Early Human Feasibility Program (Case-Based)

Presenter: Alexandre Abizaid

October 29, 2024

Presentation TCT 2024

TCT 337: Evolution of Untreated Moderate Mitral Regurgitation After Transcatheter Aortic Valve Implantation

Presenter: Massimo Baudo

October 28, 2024

Presentation TCT 2024

TCT 933: Win Ratio Analysis of LANDMARK Trial: Myval Transcatheter Heart Valve vs Contemporary Standard Valves (Sapien and Evolut) in Patients With Severe Aortic Stenosis

Presenter: Patrick Serruys

October 28, 2024

Presentation TCT 2024

TCT 165: Comparison of Paravalvular Leak in SAPIEN 3 and EVOLUT PRO Valves in Transcatheter Aortic Valve Replacement: A Multicenter Registry

Presenter: Anthony Matta

October 28, 2024

Presentation TCT 2024

TCT 1459: Valve-in-Valve With High Risk of Double Coronary Obstruction in a Degenerated Self Expandable Evolut R TAVR

Presenter: Hector Alvarez Covarrubias

October 27, 2024

Presentation TCT 2024

TCT 1566: TAVR-in-TAVR of Sapien in Evolut

Presenter: Daniel Zumerkorn Hassan

October 27, 2024

Presentation TCT 2024

Multicentric Randomized Evaluation of Transcatheter Edge-to-Edge Repair for Severe Isolated Tricuspid Regurgitation: The TRI-FR Trial: Evolution Over Time of Transthoracic Echocardiography Parameters

Presenter: Erwan Donal

October 27, 2024

Presentation NY Valves 2024

TMVR Will Rely on the Evolution of Imaging: Current Trends and Future Possibilities

Presenter: Augustin Coisne

June 07, 2024

Presentation NY Valves 2024

Where Do We Go Next?

Presenter: Roxana Mehran

June 06, 2024

Presentation NY Valves 2024

What Data and Valve Design Means for Valve Selection in Women

Presenter: Ruby Satpathy

June 06, 2024

Presentation NY Valves 2024

FX+: The Next Step in Addressing Lifetime Management

Presenter: Laura Flannery

June 06, 2024

Presentation NY Valves 2024

An Evidence Based Discussion: SMART and Evolut in Women

Presenter: Howard C. Herrmann

June 06, 2024

Presentation NY Valves 2024

Not All Valves Are Designed Alike

Presenter: Matthew W. Sherwood

June 06, 2024

Presentation NY Valves 2024

Redo TAVR Through Embolized Evolut FX Valve

Presenter: Richard Tanner

June 06, 2024

Presentation TCT 2023

TCT 906: Leaflet Thrombosis in a patient with Severe, Bicuspid Aortic Valve Stenosis and Severely Depressed LVEF: Acute Leaflet Thrombosis Less than 24 Hours After Evolut R Implantation

Presenter: Fabio Enrique Posas

October 26, 2023

Presentation TCT 2023

TCT 386: Sapien 3 in Degenerated Calcified Evolut: Assessing Hydrodynamic Function and Leaflet Kinematics After Redo-TAVR

Presenter: Janarthanan Sathananthan

October 25, 2023

Presentation TCT 2023

TCT 954: High Risk Left Main Stenting through EVOLUT Valve with Impella Support from Axillary Access

Presenter: Sze Jia Ng

October 25, 2023

Advertisement

AS in Women

Case Background and Valve Selection Discussion

Case Outcome

The Evolution of Transcatheter Mitral Valve Repair: Technical and Procedural Insights from an Early Human Feasibility Program (Case-Based)

TCT 337: Evolution of Untreated Moderate Mitral Regurgitation After Transcatheter Aortic Valve Implantation

TCT 933: Win Ratio Analysis of LANDMARK Trial: Myval Transcatheter Heart Valve vs Contemporary Standard Valves (Sapien and Evolut) in Patients With Severe Aortic Stenosis

TCT 165: Comparison of Paravalvular Leak in SAPIEN 3 and EVOLUT PRO Valves in Transcatheter Aortic Valve Replacement: A Multicenter Registry

TCT 1459: Valve-in-Valve With High Risk of Double Coronary Obstruction in a Degenerated Self Expandable Evolut R TAVR

TCT 1566: TAVR-in-TAVR of Sapien in Evolut

Multicentric Randomized Evaluation of Transcatheter Edge-to-Edge Repair for Severe Isolated Tricuspid Regurgitation: The TRI-FR Trial: Evolution Over Time of Transthoracic Echocardiography Parameters

TMVR Will Rely on the Evolution of Imaging: Current Trends and Future Possibilities

Where Do We Go Next?

What Data and Valve Design Means for Valve Selection in Women

FX+: The Next Step in Addressing Lifetime Management

An Evidence Based Discussion: SMART and Evolut in Women

Not All Valves Are Designed Alike

Redo TAVR Through Embolized Evolut FX Valve

TCT 906: Leaflet Thrombosis in a patient with Severe, Bicuspid Aortic Valve Stenosis and Severely Depressed LVEF: Acute Leaflet Thrombosis Less than 24 Hours After Evolut R Implantation

TCT 386: Sapien 3 in Degenerated Calcified Evolut: Assessing Hydrodynamic Function and Leaflet Kinematics After Redo-TAVR

TCT 954: High Risk Left Main Stenting through EVOLUT Valve with Impella Support from Axillary Access

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content